BioLife Solutions Inc (BLFS) Stock Analysis

BioLife Solutions Inc (BLFS) is a publicly traded company in the HEALTHCARE sector. It trades at $27.49, carries a market capitalization of $1.22B. This page summarizes the public market data, fundamentals, and frequently asked questions for BLFS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $27.49
• Market Cap: $1.22B
• EPS: $-0.24
• 52-Week High: $29.62
• 52-Week Low: $17.86

Market Sentiment

BioLife Solutions Inc currently has a Bullish sentiment score of 0.41.

About BioLife Solutions Inc

BioLife Solutions, Inc. is a premier provider of bioproduction tools and services that are pivotal for the gene and cell therapy industries, headquartered in Bothell, Washington. The company focuses on developing innovative solutions to optimize the preservation and processing of biological materials, which play a crucial role in the progression of life-saving therapies. With a steadfast emphasis on quality and reliability, BioLife Solutions is strategically positioned to leverage the escalat...

GNG Research Analysis

GNG Research scores BioLife Solutions Inc (BLFS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BLFS.

Frequently Asked Questions

Does BLFS pay dividends?

BioLife Solutions Inc (BLFS) does not currently pay a regular dividend.

What is BLFS's market cap?

BioLife Solutions Inc (BLFS) has a market capitalization of $1.22B with a current stock price of $27.49.